Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Here's my best i-Dialco guess
View:
Post by mercedesman on Jan 20, 2023 3:18pm

Here's my best i-Dialco guess

(and it shouldn't have to be a guess)
  • Infomed to take the lead on US Distribution efforts (and fund the costs of same)
  • hire the right team, including a new President, based in the US (big $ investment required by Infomed). Maybe this is why they gave up 20% of US
  • FDA and Health Canada approval on dialysate bags (1 year?).  Can't use DIMI without that.
  • resolve tubing sourcing and ramp up production capacity for 2025+  (to service US market)
  • await clarity on US insurance coverage for Home Dialysis
  • start 30 person trial in 2023
  • Sometime after or during the above - take on a Distribution partner (partial monetization). 
  • Expand market for SAMI as a portable device that can be used once PMX approved (alongside Baxter's Prism).   Including for Europe (spectral owns that patent)

Little to no Dialco value reflected (yet) in Spectral SP (despite 30% stake in i-Dialco)

If a Spectral/PMX/EAA deal in consumated in 2023, then i-Dialco gets spun out to Spectral shareholders (= monetization).

All JIMHO

MM
Comment by hmmmmmmmm on Jan 20, 2023 6:08pm
The issue IS the not knowing/ guessing.   Without disclosure we do not know..   How will i-Dialco be funded? If Infomed brings on Partners or does a financing- what does that do to Spectral's percentage?   Infomed doesn’t even mention the FDA trial for DIMI. It is very conspicuously absent from their note. So what do they see as the way forward for DIMI?   ...more  
Comment by mercedesman on Jan 20, 2023 10:27pm
I agree with tou more disclosure is not only warranted, it is of paramount importance, and the least they could do for loyal shareholders who have tied up their hard earned money.  I probably own ( very small to small pieces of) more than 100 different public companies ... I can't think of one where Mgt doesn't periodically share their strategic plans for the future with ...more  
Comment by hmmmmmmmm on Jan 21, 2023 1:58am
Yeah, except Infomed doesn't mention Spectral or a a joint venture in their news release. They actually call i-Dialco their "subsidiary". We paid for the FDA approvals of SAMI and DIMI. The approvals were in Spectral's name and were probably worth the 30%. A fight over them could have tied up any N American progress for years.  But as Spectral continues to ...more  
Comment by hmmmmmmmm on Jan 21, 2023 2:04am
I want to correct the first line of my previous post. I found a longer version of the release and it does mention the joint venture with Dialco which is owned by Spectral.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities